Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility

NCT: NCT03641677 · COMPLETED

NCT IDNCT03641677
StatusCOMPLETED
Start Date2019-04-21
Completion2024-01-18
SponsorLung Bioengineering Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to evaluate the safety and effectiveness of the Centralized Lung Evaluation System (CLES) in enabling evaluation of potential donor lungs not otherwise used for transplant into subjects with end stage, survival-limiting lung disease in need of lung transplantation. This will be accomplished by evaluating subject survival at the later of 12 months or hospital discharge post-transplant.

Frequently Asked Questions

What is Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility?

Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility is a clinical trial registered under NCT03641677. Current status: COMPLETED.

What is the status of NCT03641677?

The current status of NCT03641677 (Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility) is: COMPLETED.

When did Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility start?

Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility started on 2019-04-21.

Related Devices

PMA P240033Normothermic preservation system for transplantation of initially unacceptable donor lungsLung Bioengineering, Inc. PMA P160013Normothermic machine perfusion system for the preservation of standard criteria donor lungs prior to transplantationTransMedics, Inc. PMA P180014Normothermic preservation system for transplantation of initially unacceptable donor lungsXvivo Perfusion, Inc. PMA P200031Normothermic machine perfusion system for the preservation of donor livers prior to transplantationTransMedics, Inc. PMA P200035Normothermic machine perfusion system for the preservation of donor livers prior to transplantationOrganox Limited

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑